• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Computer Concepts for Medical Device Design

    IVD Manufacturers Are Being Put to the Test

    The New State of Medtech Outsourcing

    The Changing Face of Medtech Surface Treatment

    The Totally Tubular Technologies that Support Medical Devices
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    CareDx, Miromatrix Collaborate on Bioengineered Organs Research

    Capitainer Releases to Market its Fully Automated Sample Handler

    Titan Medical Licenses Most IP to Intuitive; CEO Steps Down

    Nox Medical Secures New Patent for Calculating Respiratory Effort During Sleep Studies

    Concept Medical Earns 4th FDA IDE Nod for MagicTouch PTA
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Computer Concepts for Medical Device Design

    IVD Manufacturers Are Being Put to the Test

    The New State of Medtech Outsourcing

    The Changing Face of Medtech Surface Treatment

    The Totally Tubular Technologies that Support Medical Devices
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Checking Up on Surgical Robotics

    Building a Network: How Synchron Is Developing a New Device—and a New Market

    Six Lessons Learned on Developing a Strong Company Culture

    As Hiring Slows, Companies Look Inward to Fulfill Talent Needs

    Artificial Intelligence: Medtech Opportunity or Health Danger?
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Medbio LLC

    Fusion Biotec Inc.

    Arthur G. Russell Co. Inc., The

    JBC Technologies

    LEMO USA Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    6 Considerations for Companies on the Cusp of Being Acquired

    3 Key Elements to Consider When Managing a Medtech Sales Force

    Tech-Enabled Virtual Speech Therapy Improves Speech & Communication Skills

    Practical Strategies for Digitization and Integration in Medtech Manufacturing

    Sensors: The Heart of Minimally Invasive Equipment Technology
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Medbio LLC

    Fusion Biotec Inc.

    Arthur G. Russell Co. Inc., The

    JBC Technologies

    LEMO USA Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Baxter's Q1 Revenue Rises 4 Percent

    Company increases full-year 2017 sales growth outlook to 1 to 2 percent.

    Business Wire05.03.17
    It's been a good year so far for Baxter International Inc.

    Revenue and earnings per share both increased in the first quarter, bolstered by strong U.S. sales and product innovation.
     
    “Encouraged by a solid start to 2017 and the on-going momentum of our business transformation initiatives, we are raising our full-year sales and earnings outlook,” said José (Joe) E. Almeida, chairman and CEO. “We are driving growth through disciplined execution and particular strength across our U.S. businesses. We will continue to invest in evolving our portfolio through the introduction of innovative products and technologies along with geographic expansion to deliver future growth.”
     
    First-Quarter Financial Results
    In the first quarter (ended March 31), worldwide sales totaled $2.5 billion, an increase of 4 percent on a reported basis and 5 percent on a constant currency basis compared with Q1 2016. Operationally, Baxter’s sales rose 7 percent, which excludes the impact of foreign exchange, generic competition for U.S. cyclophosphamide and the previously communicated select strategic product exits the company is undertaking.
     
    U.S. sales were $1.1 billion, advancing 11 percent on a reported basis. International sales of $1.4 billion declined 1 percent on a reported basis and were comparable to the prior year on a constant currency basis. Baxter’s operational sales increased 13 percent in the United States and 2 percent internationally.
     
    Global sales for Hospital Products totaled $1.6 billion in the first quarter, increasing 7 percent on both a reported and constant currency basis and advancing 10 percent operationally as compared to the prior-year period. Contributing to performance in the quarter were strong U.S. sales of IV therapies, IV access sets, and select anesthesia and critical care products along with favorable demand for parenteral nutrition therapies and international biosurgery products.
     
    Baxter’s Renal sales totaled $896 million, comparable to the first quarter of 2016 on a reported basis and grew 1 percent globally on a constant currency basis. Operationally, global Renal sales advanced 2 percent benefitting from increased sales of peritoneal dialysis therapies driven by the continued adoption of the company’s newest Automated Peritoneal Dialysis (APD) cyclers—AMIA in the United States and HOMECHOICE CLARIA in international markets. Additionally, sales of Baxter’s acute renal care products advanced globally, reflecting growing demand for continuous renal replacement therapies (CRRT).
     
    Baxter reported income from continuing operations of $273 million, or 50 cents per diluted share, on a GAAP (Generally Accepted Accounting Principles) basis for the first quarter. These results included special items totaling $62 million ($45 million net after-tax), primarily related to business optimization and intangible asset amortization.
     
    On an adjusted basis, excluding special items, Baxter’s first quarter income from continuing operations totaled $318 million, or 58 cents per diluted share, exceeding the company’s previously issued guidance of 50 cents to 52 cents per diluted share.
     
    Baxter achieved a number of operational, pipeline and commercial milestones during the first quarter to support its strategy to drive accelerated growth and deliver meaningful innovation.
     
    In Surgical Care:
    • The company introduced customer-centric enhancements to Baxter’s hemostatic agents, FLOSEAL and TISSEEL, designed to enhance patient safety and ease of use for clinicians.
    • Baxter published two health economic data analyses in the Journal of Medical Economics supporting FLOSEAL as a cost-effective hemostat that may contribute to broader cost savings at hospitals as compared to other options.
    • The company acquired Wound Care Technologies Incorporated, manufacturer of the DERMACLOSE Continuous Tissue Expander, a wound closure technology that is complementary to Baxter’s surgical portfolio and directly leverages its existing expertise and channel strength.
    In Renal:
    • Surpassed 500,000 patient treatments administered globally utilizing Baxter’s SHARESOURCE Connectivity Platform. SHARESOURCE is the first and only two-way remote patient management system for home dialysis therapy and is available on both AMIA and HOMECHOICE CLARIA APD cyclers.
    • Successful deployment of PRISMAX, Baxter’s next generation continuous renal replacement therapy platform, in several European locations as part of an initial limited distribution prior to the planned full-scale launch in 2018.
     
    Based on the company’s strong first quarter, Baxter is raising its financial outlook for the year. The company now expects sales growth of approximately 1 percent to 2 percent on a reported basis or 2 percent to 3 percent on a constant currency basis, and earnings from continuing operations, before special items, of $2.20 to $2.28 per diluted share for the full year. Adjusting for the impact of generic cyclophosphamide competition (an estimated 1 percent) and selected strategic product exits (an estimated 1 percent), Baxter expects underlying constant currency sales growth of approximately 4 percent to 5 percent. This guidance does not include any impact from the company’s proposed acquisition of Claris Injectables, which is expected to close in the second half of 2017.
     
    For the second quarter: The company expects flat sales growth on a reported basis, or approximately 2 percent on a constant currency basis. Adjusting for the impact of generic cyclophosphamide competition (less than an estimated 0.5 percent) and selected strategic product exits (less than an estimated 1 percent), Baxter expects underlying constant currency sales growth of approximately 3 percent. The company expects earnings from continuing operations, before special items, of 55 cents to 57 cents per diluted share.
    Related Searches
    • closure
    • constant currency basis
    • innovation
    • acquisition
    Suggested For You
    Baxter and Mayo Clinic Launch R&D Collaboration Baxter and Mayo Clinic Launch R&D Collaboration
    Positive Results from Boston Scientific Positive Results from Boston Scientific's Bronchial Thermoplasty Study
     Baxter Achieves Regulatory Milestone for New Peritoneal Dialysis Technology Baxter Achieves Regulatory Milestone for New Peritoneal Dialysis Technology
    Wearable Cardioverter Defibrillators Proven Safe for Children at Risk of Sudden Cardiac Arrest Wearable Cardioverter Defibrillators Proven Safe for Children at Risk of Sudden Cardiac Arrest
    What’s New in the ED? What’s New in the ED?
    International Law International Law
    Teleflex Completes Acquisition of Pyng Medical Corp. Teleflex Completes Acquisition of Pyng Medical Corp.
    New Data Indicates Use of Baxter’s FLOSEAL May be Associated With Lower Hospital Costs New Data Indicates Use of Baxter’s FLOSEAL May be Associated With Lower Hospital Costs
    Medical Device Recalls and Units Medical Device Recalls and Units
    Entellus Medical Reports 22 Percent Surge in 2016 Revenue Entellus Medical Reports 22 Percent Surge in 2016 Revenue
    Invuity Reports 50 Percent Growth in Revenues in Q4 Invuity Reports 50 Percent Growth in Revenues in Q4
    More Than 7 Million Patients Use Remote Monitoring, Connected Devices as Part of Their Healthcare More Than 7 Million Patients Use Remote Monitoring, Connected Devices as Part of Their Healthcare
     MedTech Industry Lost Nearly 29,000 Jobs While Device Tax In Effect MedTech Industry Lost Nearly 29,000 Jobs While Device Tax In Effect
    Avinger Announces 24-Month Outcomes from the Pivotal VISION Study Avinger Announces 24-Month Outcomes from the Pivotal VISION Study
    MedTech Innovator Calls for Emerging Companies to Apply MedTech Innovator Calls for Emerging Companies to Apply

    Related Breaking News

    • R&D & Design
      Baxter and Mayo Clinic Launch R&D Collaboration

      Baxter and Mayo Clinic Launch R&D Collaboration

      The first project will focus on kidney disease, with additional projects planned in other areas.
      Business Wire 05.31.17

    • Surgical
      Positive Results from Boston Scientific

      Positive Results from Boston Scientific's Bronchial Thermoplasty Study

      Results from evaluation of real-world patients presented at American Thoracic Society International Conference.
      PR Newswire 05.25.17

    •  Baxter Achieves Regulatory Milestone for New Peritoneal Dialysis Technology

      Baxter Achieves Regulatory Milestone for New Peritoneal Dialysis Technology

      New system may reduce barriers and offer more patients access to home therapy.
      Business Wire 05.18.17


    • Cardiovascular
      Wearable Cardioverter Defibrillators Proven Safe for Children at Risk of Sudden Cardiac Arrest

      Wearable Cardioverter Defibrillators Proven Safe for Children at Risk of Sudden Cardiac Arrest

      Largest study of its kind finds device effective in detecting and treating life-threatening arrhythmias.
      Heart Rhythm Society 05.11.17

    • What’s New in the ED?

      What’s New in the ED?

      ...
      Maria Shepherd, President and Founder, Medi-Vantage 05.01.17

    Loading, Please Wait..

    Trending
    • AVS Collects An Additional $8.8 Million In Its Series B Funding Round
    • Philips Names New Supervisory Board Chairman
    • Healthcare Changes Prompt Medtronic To Merge Sales Force Medtronic, Inc. Is Combining Its U.S. Ca
    • Medtronic To Buy Wearable Insulin Patch Maker EOFlow For $738M
    • Noah Medical's Galaxy System Achieves First U.S. Robotic Bronchoscopy
    Breaking News
    • CareDx, Miromatrix Collaborate on Bioengineered Organs Research
    • Capitainer Releases to Market its Fully Automated Sample Handler
    • Titan Medical Licenses Most IP to Intuitive; CEO Steps Down
    • Nox Medical Secures New Patent for Calculating Respiratory Effort During Sleep Studies
    • Concept Medical Earns 4th FDA IDE Nod for MagicTouch PTA
    View Breaking News >
    CURRENT ISSUE

    May 2023

    • Computer Concepts for Medical Device Design
    • IVD Manufacturers Are Being Put to the Test
    • The New State of Medtech Outsourcing
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Verdure Sciences Receives Award for Sustainable, Ethical Turmeric Sourcing
    BGG Receives Patent for Saw Palmetto ID Method
    Premium Label & Packaging Solutions Receives Safe Quality Food (SQF) Certification
    Coatings World

    Latest Breaking News From Coatings World

    Boeing Starts Construction on New St. Louis Facility
    Brand Finance: Post-COVID Recovery Slows for Chemicals Industry Battling Energy Crisis
    BCF Calls for Greater Urgency on REACH Impasse
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    CareDx, Miromatrix Collaborate on Bioengineered Organs Research
    Capitainer Releases to Market its Fully Automated Sample Handler
    Titan Medical Licenses Most IP to Intuitive; CEO Steps Down
    Contract Pharma

    Latest Breaking News From Contract Pharma

    AVROBIO Sells Cystinosis Gene Therapy for $87.5 Million
    Meiji Seika Pharma, Adcock Ingram Pharma Complete Construction of New Manufacturing Facility
    JSR Life Sciences Consolidates KBI Biopharma and Selexis SA
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Unilever Uses AI for Product Development
    Beautycounter Names New Interim CEO
    Shaz & Kiks Available at Sephora
    Happi

    Latest Breaking News From Happi

    Covergirl Introduces Clean Fresh Yummy Gloss Collection
    Shaz and Kiks Launches at Sephora
    Beautycounter Appoints Board Director Mindy Mackenzie Interim CEO
    Ink World

    Latest Breaking News From Ink World

    ACTEGA, Makro Labelling to Advance Signite Technology
    BCF Requests Greater Urgency on REACH Impasse
    Updated Method Published for Entire BASF Product Portfolio
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    ACTEGA teams with Makro Labelling to advance Signite technology
    Constantia Flexibles and SB Packagings commence joint venture
    Inland donates new VersaStudio printer to local high school
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Mann+Hummel Names President Air Filtration Americas
    KNH Launches Eco-Friendly Menstrual Pads
    Niine Introduces India's First PLA-Based Sanitary Pads
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Enrollment Completed in Anika Therapeutics' Hyalofast Study
    Exactech Releases Next-Gen GPS Shoulder
    Data Shows Favorable Survivorship of MISHA Knee System & Reduction of Arthroplasty Risk in Patients
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    onsemi Presents Path to Accelerate Revenue Growth
    STMicroelectronics Introduces Waterproof MEMS Pressure Sensor
    Graphene Flagship to Join Euro Nano Forum 2023

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login